VestGen Advisors LLC Has $2.60 Million Stake in UnitedHealth Group Incorporated $UNH

VestGen Advisors LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 45.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,588 shares of the healthcare conglomerate’s stock after selling 7,159 shares during the quarter. VestGen Advisors LLC’s holdings in UnitedHealth Group were worth $2,595,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. BLI Banque de Luxembourg Investments grew its holdings in shares of UnitedHealth Group by 1.0% in the 2nd quarter. BLI Banque de Luxembourg Investments now owns 107,530 shares of the healthcare conglomerate’s stock valued at $33,230,000 after acquiring an additional 1,020 shares in the last quarter. Tobias Financial Advisors Inc. increased its position in shares of UnitedHealth Group by 8.5% during the 2nd quarter. Tobias Financial Advisors Inc. now owns 768 shares of the healthcare conglomerate’s stock worth $240,000 after purchasing an additional 60 shares during the last quarter. PACK Private Wealth LLC boosted its holdings in shares of UnitedHealth Group by 47.6% in the 2nd quarter. PACK Private Wealth LLC now owns 9,569 shares of the healthcare conglomerate’s stock valued at $2,985,000 after buying an additional 3,087 shares during the last quarter. Legacy Capital Wealth Partners LLC increased its holdings in UnitedHealth Group by 4.5% during the second quarter. Legacy Capital Wealth Partners LLC now owns 3,561 shares of the healthcare conglomerate’s stock worth $1,111,000 after buying an additional 154 shares during the last quarter. Finally, Pursue Wealth Partners LLC grew its position in shares of UnitedHealth Group by 1,566.2% in the 2nd quarter. Pursue Wealth Partners LLC now owns 8,581 shares of the healthcare conglomerate’s stock valued at $2,677,000 after acquiring an additional 8,066 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $329.75 on Monday. The firm has a market capitalization of $298.70 billion, a PE ratio of 17.21, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $622.83. The stock’s 50-day simple moving average is $343.37 and its 200 day simple moving average is $314.95.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the firm posted $7.15 EPS. The firm’s revenue was up 12.2% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. UBS Group boosted their price target on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Sanford C. Bernstein increased their price target on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Truist Financial upped their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Eighteen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.